New transplant strategy aims to stop lymphoma from spreading to the brain
NCT ID NCT07481669
Summary
This study is testing a modified chemotherapy regimen given before a patient's own stem cells are transplanted back into them. It is for people with non-Hodgkin lymphoma who are at high risk of the cancer spreading to their brain or spinal cord. The goal is to see if this approach is more effective, less toxic, and more affordable than older methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA PATIENTS WITH HIGH-RISK OF CENTRAL NERVOUS SYSTEM RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.